Safety and clinical efficacy of abetimus sodium (LJP-394) in prevention of renal flares in patients with systemic lupus erythematosus and a history of renal disease.
Phase of Trial: Phase III
Latest Information Update: 04 Jul 2012
At a glance
- Drugs Abetimus (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 04 Aug 2011 New trial record